سعر لوميجان 0.03 % قطرة للعين 3 مل 2022

Lumigan (Allergan) bimatoprost 0.03% eye drops, 3 ml: a prostamide (prostaglandin analogue) used once daily to lower raised intraocular pressure in open-angle glaucoma and ocular hypertension.

• Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (monotherapy or adjunctive to beta-blockers).Population: Adultselectronic medicines compendium (emc), UK
• Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.DailyMed (U.S. National Library of Medicine)

• Very common: conjunctival hyperaemia (up to 44% in year 1), eyelash growth (up to 45%), ocular pruritus (up to 14%), periorbitopathy. Common: headache, hypertension, superficial punctate keratitis, ocular burning/irritation, dry eye, eye pain, blurred vision, increased iris pigmentation, eyelid erythema, abnormal liver function tests. Uncommon: dizziness, nausea, retinal haemorrhage, uveitis, cystoid macular oedema.International label, same formulation · electronic medicines compendium (emc), UK
• Postmarketing: asthma-like symptoms, dyspnoea, dizziness, eyelid oedema, hypersensitivity, hypertension, nausea, periorbital fat atrophy with deepening of the eyelid sulcus and ptosis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to bimatoprost or any excipient; previous suspected adverse reaction to benzalkonium chloride that led to discontinuation.International label, same formulation · electronic medicines compendium (emc), UK

• Prostaglandin analogue periorbitopathy: eyelash growth, darkening of the eyelid skin and increased (likely permanent) brown iris pigmentation; may cause differences between the eyes if only one eye is treated.International label, same formulation · electronic medicines compendium (emc), UK
• Cystoid macular oedema (uncommon): use with caution in aphakic patients, pseudophakic patients with torn posterior capsule or other risk factors.International label, same formulation · electronic medicines compendium (emc), UK
• Caution with prior significant ocular viral infection (e.g. herpes simplex) or uveitis/iritis; not studied in inflammatory, neovascular, angle-closure, congenital or narrow-angle glaucoma.International label, same formulation · electronic medicines compendium (emc), UK

• Other prostaglandin analogues (ophthalmic)The IOP-lowering effect may be reduced when used with other prostaglandin analogues. No interactions anticipated systemically (plasma levels below 0.2 ng/ml); used with ophthalmic beta-blockers without evidence of interaction.electronic medicines compendium (emc), UK

• No adequate data in pregnant women; animal studies showed reproductive toxicity at high maternotoxic doses. Should not be used during pregnancy unless clearly necessary.International label, same formulation · electronic medicines compendium (emc), UK
• No increase in the risk of major birth defects or miscarriage based on postmarketing experience; abortion and early delivery in rodents only at oral exposures at least 33 times human exposure.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Unknown whether excreted in human milk (excreted in animal milk); decide whether to discontinue breastfeeding or therapy.International label, same formulation · electronic medicines compendium (emc), UK

• Bimatoprost: Synthetic prostamide structurally related to prostaglandin F2-alpha; lowers intraocular pressure by increasing aqueous humour outflow through the trabecular meshwork and the uveoscleral pathway.